Literature DB >> 4003575

Reflex control of osmotically stimulated vasopressin in normal humans.

S R Goldsmith, A W Cowley, G S Francis, J N Cohn.   

Abstract

Previous studies have shown that in normal humans plasma arginine vasopressin (AVP) does not increase in response to unloading of cardiopulmonary and sinoaortic baroreceptors produced by lower body negative pressure (LBNP) unless hypotension occurs. To assess whether prior osmotic stimulation of AVP might bring out latent sensitivity to nonosmotic control mechanisms in humans we studied the response of plasma AVP to graded LBNP after a 105-min infusion of 5% saline in a group of eight normal individuals. During the infusion and before LBNP, serum osmolality increased from 288 +/- 9 to 300 +/- 10 mosmol/kg, and plasma AVP increased from 4.4 +/- 1.7 to 8.0 +/- 2.5 pg/ml. Neither osmolality nor AVP changed significantly during two stages of LBNP that first reduced central venous pressure alone and then reduced central venous pressure with accompanying tachycardia and narrowing of the pulse pressure. Time control studies performed in five individuals subjected to central venous catheterization and an identical hypertonic saline infusion failed to show significant spontaneous changes in AVP during a comparable interval after the infusions but without LBNP. Thus osmotic stimulation with hypertonic saline did not render AVP more sensitive to nonhypotensive unloading of cardiopulmonary and sinoaortic baroreceptors in normal humans.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4003575     DOI: 10.1152/ajpregu.1985.248.6.R660

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.

Authors:  David E Lanfear; Hani N Sabbah; Steven R Goldsmith; Stephen J Greene; Andrew P Ambrosy; Angela J Fought; Mary J Kwasny; Karl Swedberg; Clyde W Yancy; Marvin A Konstam; Aldo P Maggioni; Faiez Zannad; Mihai Gheorghiade
Journal:  Circ Heart Fail       Date:  2012-12-12       Impact factor: 8.790

2.  The prognostic value of brain natriuretic peptide in patients with heart failure and left ventricular ejection fraction higher than 60%: a sub-analysis of the J-MELODIC study.

Authors:  Shuichi Kitada; Shohei Kikuchi; Takeshi Tsujino; Tohru Masuyama; Nobuyuki Ohte
Journal:  ESC Heart Fail       Date:  2017-09-21

3.  Elevation of arginine vasopressin levels following loop diuretic therapy as a prognostic indicator in heart failure.

Authors:  Shuichi Kitada; Shohei Kikuchi; Hiroo Sonoda; Atsuhiro Yoshida; Nobuyuki Ohte
Journal:  J Int Med Res       Date:  2016-10-27       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.